The FDA blessed ExAblate after one trial in which 42 of 82 women with fibroids had their tumors disappear, or shrink to less bothersome levels within one year.
As the art directors scrambled to address last-minute requests and the copywriters (including yours truly) banged away on final, final versions of those blessed sentences no one supposedly reads anymore, it started raining hard as hell with thunder and lightning, a major rarity in Northern California.